Don't miss today's Nasdaq standout! GT Biopharma, Inc. (GTBP)
Published: Fri, 03/22/24
Dear Reader, Don't miss today's Nasdaq standout! GT Biopharma, Inc. (GTBP) is making waves with a remarkable 20% surge. Why does this matter? Here's a…
A mailing list to regularly send out updates about MarketTips.net
Published: Fri, 03/22/24
Dear Reader, Don't miss today's Nasdaq standout! GT Biopharma, Inc. (GTBP) is making waves with a remarkable 20% surge. Why does this matter? Here's a…
Published: Fri, 03/22/24
Dear Reader, We apologize for the oversight in our previous email. The correct ticker symbol for GT Biopharma Inc. is (NASDAQ: GTBP). Ready to e plore…
Published: Fri, 03/22/24
Dear Reader, Are you keeping an eye out for new opp’s in the biopharmaceutical sector? If so, we have an e citing new profile for you: GT Biopharma…
Published: Thu, 03/21/24
Dear Reader, We're bubbling with e citement as we gear up to share something truly remarkable with you – an e clusive profile of an under-the-radar…
Published: Thu, 03/21/24
Dear Reader, I hope this message finds you in high spirits and ready for some electrifying news! Today marks a momentous occasion in the biotech realm…
Published: Thu, 03/21/24
Dear Reader, I hope this email finds you well and ready for some e hilarating news! Today marks a thrilling moment in the biotech world as XORTX…
Published: Thu, 03/21/24
Dear Reader, I hope this email finds you well and ready to delve into an e citing company profile! Today, I'm thrilled to introduce you to a company…
Published: Wed, 03/20/24
Dear Reader, I hope this email finds you thriving and ready for some e citing news! Today, I have the pleasure of introducing you to a company that's…
Published: Wed, 03/20/24
Dear Reader, I hope this email finds you well! I wanted to drop you a line and share some thrilling news that's been buzzing in the biotech world.
Published: Wed, 03/20/24
Dear Reader, ANIX opened strong today and hit a high of $3.89, which is a 11% gain from Monday’s close of $3.51. Keep an eye on this one! In the ever-…